This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
The Trump administration recently released the final rule pertaining to short-term and limited-duration insurance coverages. The new order provides cheaper and effective short-term health plans to individuals and businesses that find policies under Obamacare unaffordable.
PRU GD AVF PFK MET FSPCX AIG MET PRH CB 8685 PJH
MetLife Inc.’s (MET - Free Report) second-quarter 2018 earnings release scheduled on Aug 1 is expected to showcase revenue growth on the back of sales growth in Asia and EMEA, growth in operating premiums plus fees and other revenues in its Group Benefits segment.
AFW MET AFGE XL AFA AFGH NMIH MET AFG XLGLF
Good day, and welcome to the Majesco Fiscal 2019 First Quarter Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Andrew Berger, Investor Relations. Please go ahead.
MET MJCO MET MJCO
2018-07-06 247wallst - 1
July 6, 2018: Here are four stocks trading with heavy volume among 32 equities making new 52-week lows in Friday’s session. On the NYSE advancers led decliners by about 2.7 to 1 and on the Nasdaq, advancers led decliners by about 2.35 to 1.
RGLS MNGA MET MDXG MET
Chicago, IL – June 28, 2018 - Stocks in this week’s article include: Domtar Corp. (UFS - Free Report) , Hitachi Ltd. (HTHIY - Free Report) , ArcelorMittal (MT - Free Report) , Metlife Inc. (MET - Free Report) and Xcerra Corp. (XCRA - Free Report) .
ROP WLL UFS MET LXFR WCG WTW ICHR XCRA JOUT MET MT TWIN 6501 SEDG HTHIY MT
A stock’s price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by the company. If the price-to-sales ratio is 1, it means that investors are paying $1 for every $1 of revenues generated by the company. So, it goes without saying that a stock with a price-to-sales below 1 is a good bargain, as investors need to pay less than a dollar for a dollar’s worth.
MGP UFS MET ICHR XCRA MET MT 6501 SCVL HTHIY MT
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
BOSTON (Reuters) - Massachusetts’ securities regulator on Monday accused MetLife Inc of making false statements relating to its failure to pay pensions to hundreds of retirees in the state that it improperly treated as “presumed dead.”
Chicago, IL – June 13, 2018 - Stocks in this week’s article include: MGM Growth Properties LLC (MGP - Free Report) , Metlife Inc. (MET - Free Report) , Citizens Financial Group Inc. (CFG - Free Report) , ArcelorMittal (MT - Free Report) and Daqo New Energy Corp. (DQ - Free Report) .
ELY ACCO MGP MET LXFR WTW GIII MAR.WI CFG CFIN MAR MET DQ MT DK CIWV ENBL URBN HLT MT KOS AAXN
When considering valuation metrics, price-to-earnings ratio has always been the obvious choice as calculations based on earnings are easy and come in handy. However, price-to-sales has emerged as a convenient tool to determine the value of stocks that are incurring losses or are in an early cycle of development, generating meager or no profits. While a loss-making company with a negative price-to-earnings ratio falls out of investor favor, price-to-sales could indicate the hidden strength of its business.
MGP MET XCRA CFG CFIN MET DQ MT CIWV PWR MT
U.S. companies already established in Japan want the Trump administration to focus more on service-sector trade than on market access for manufacturers, according to the American Chamber of Commerce in Japan.
MET GEC GE MET GNE
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...